Multi-Omic Platform-Guided Tumor Metabolism Characterization Service

Omic Platforms for Tumor Metabolism Characterization

At Creative Biolabs, we are committed to providing customers with comprehensive and accurate information about metabolic changes in tumor cells and their microenvironment. We use advanced technologies to measure the metabolic changes in tumor cells and provide customers with comprehensive data analysis and interpretation services. By accurately analyzing the metabolic changes, we can help customers better understand the characteristics and heterogeneity of tumors, develop new therapeutic strategies, and evaluate the therapeutic effect of new drugs. In addition, we also provide customers with technical support and consultation services to help them better understand and apply metabolic analysis technology.

The workflow of omics platforms. Fig.1 The workflow of omics platforms.1

Our Multi-Omic Platforms

We can assist you with the following:

  • Metabolomics
Metabolomics has made it possible to simultaneously measure hundreds of metabolites, providing a more comprehensive understanding of tumor metabolism. This innovative technology allows us to identify specific metabolic markers that may be associated with tumor growth, progression, and response to treatment. By analyzing these markers, we can gain insights into the complex biological processes that occur within tumor cells and their microenvironment.
  • Fluxomics
Fluxomics is a related technology that allows us to measure the flux of metabolites through multiple metabolic pathways simultaneously. This approach provides a more comprehensive understanding of how tumors utilize various nutrients and produce energy. By combining metabolomics and fluxomics, we can gain a more comprehensive understanding of tumor metabolism and its regulation.
  • Genomics
  • Transcriptomics
  • Proteomics
In addition to our metabolomics services, we also offer a range of other proteomics and genomics services to provide customers with a comprehensive understanding of their samples. Through our proteomics services, we can analyze the expression and modification of proteins, shedding light on their role in tumorigenesis and progression. Our genomics services, including transcriptomics, allow us to study the genetic landscape of tumors at the RNA level and understand the complex genetic basis of cancer.

Why Choose Creative Biolabs

Experienced experts in our team have extensive knowledge and an in-depth understanding of metabolic research. They can provide you with high-quality data and professional advice.

We utilize the most advanced technology platforms to measure the metabolic changes in tumor cells and their surrounding environment. These technologies can provide detailed information about tumor cell metabolism, which helps you understand the characteristics of tumor cells more deeply.

We not only provide raw data but also provide you with comprehensive data analysis and interpretation services. Our experts will help you interpret data and provide in-depth insights on tumor cell metabolism. This will help you better understand the metabolic mechanism of tumor cells and provide guidance for the development of new therapeutic strategies.

Our team will provide you with comprehensive support, including technical consulting, data analysis interpretation, and project progress reports. We will cooperate closely with you to ensure that your project is completed and your expectations are achieved.

Let Our Experts Start Your Project

Whether you require help with your proteomics, genomics, or metabolomics experiments, our team of experts is here to support you every step of the way. In addition, we also provide customers with technical support and consultation services to help them better understand and apply metabolic analysis technology. We are looking forward to working with you to further your research in the field of tumor metabolism.

Reference

  1. Yoon, Sang Jun, et al. "The comprehensive "Omics" approach from metabolomics to advanced omics for development of immune checkpoint inhibitors: Potential strategies for next generation of cancer immunotherapy." International Journal of Molecular Sciences 22.13 (2021): 6932.

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2024 Creative Biolabs. All Rights Reserved.